These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 24260554
1. Thrombolytic effects of the snake venom disintegrin saxatilin determined by novel assessment methods: a FeCl3-induced thrombosis model in mice. Kwon I, Hong SY, Kim YD, Nam HS, Kang S, Yang SH, Heo JH. PLoS One; 2013; 8(11):e81165. PubMed ID: 24260554 [Abstract] [Full Text] [Related]
2. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Hong SY, Koh YS, Chung KH, Kim DS. Thromb Res; 2002 Jan 01; 105(1):79-86. PubMed ID: 11864711 [Abstract] [Full Text] [Related]
3. Acute and repeated dose toxicity studies of recombinant saxatilin, a disintegrin from the Korean snake (Gloydius saxatilis). Sohn YD, Hong SY, Cho KS, Choi WS, Song SW, Bae JS, Kim DS, Chung KH. Toxicon; 2008 Mar 01; 51(3):406-17. PubMed ID: 18155118 [Abstract] [Full Text] [Related]
4. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet. Chang CH, Chung CH, Tu YS, Tsai CC, Hsu CC, Peng HC, Tseng YJ, Huang TF. Arterioscler Thromb Vasc Biol; 2017 Jul 01; 37(7):1307-1314. PubMed ID: 28596377 [Abstract] [Full Text] [Related]
7. Suppressive effect and mechanism of saxatilin, a disintegrin from Korean snake (Gloydius saxatilis), in vascular smooth muscle cells. Sohn YD, Cho KS, Sun SA, Sung HJ, Kwak KW, Hong SY, Kim DS, Chung KH. Toxicon; 2008 Sep 01; 52(3):474-80. PubMed ID: 18625263 [Abstract] [Full Text] [Related]
8. A Novel αIIbβ3 Antagonist from Snake Venom Prevents Thrombosis without Causing Bleeding. Kuo YJ, Chung CH, Pan TY, Chuang WJ, Huang TF. Toxins (Basel); 2019 Dec 21; 12(1):. PubMed ID: 31877725 [Abstract] [Full Text] [Related]
9. RUC-4: a novel αIIbβ3 antagonist for prehospital therapy of myocardial infarction. Li J, Vootukuri S, Shang Y, Negri A, Jiang JK, Nedelman M, Diacovo TG, Filizola M, Thomas CJ, Coller BS. Arterioscler Thromb Vasc Biol; 2014 Oct 21; 34(10):2321-9. PubMed ID: 25147334 [Abstract] [Full Text] [Related]
10. Effect of aspirin on platelet desaggregation induced by SR121566, a potent GP-IIb/IIIa antagonist. Savi P, Bernat A, Lalé A, Roque C, Zamboni G, Herbert JM. Platelets; 2000 Feb 21; 11(1):43-8. PubMed ID: 10938881 [Abstract] [Full Text] [Related]
11. Saxatilin, a snake venom disintegrin, regulates platelet activation associated with human vascular endothelial cell migration and invasion. Jang YJ, Jeon OH, Kim DS. J Vasc Res; 2007 Feb 21; 44(2):129-37. PubMed ID: 17215584 [Abstract] [Full Text] [Related]
13. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo. Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH. J Cardiovasc Pharmacol; 1997 Aug 21; 30(2):261-72. PubMed ID: 9269956 [Abstract] [Full Text] [Related]
19. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation. Okuda D, Morita T. J Biochem; 2001 Sep 21; 130(3):407-15. PubMed ID: 11530017 [Abstract] [Full Text] [Related]
20. LX0702, a novel snake venom peptide derivative, inhibits thrombus formation via affecting the binding of fibrinogen with GPIIb/IIIa. Kong Y, Wang Y, Yang W, Xie Z, Li Z. J Pharmacol Sci; 2015 Apr 21; 127(4):462-6. PubMed ID: 25913760 [Abstract] [Full Text] [Related] Page: [Next] [New Search]